Feng Li, MD, MPH, MS

  • Research Instructor, Department of Ophthalmology
  • System Manager, the Live Animal Imaging Module, DMEI LAICore Systems Analyst,

Special Interests

  • Investigating the efficacy of pharmaceutical drugs on the prevention of retinal degenerations.
  • Understanding the relative sensitivity of different rodent species and strains to acute and chronic light stress.
  • Application of non-invasive techniques (OCT, ERG, funduscopy, and Optometry) to measure retinal structure and function in rodent models of retinal degeneration.

Training

  • M.D., Medicine, Fujian Medical University, Fujian, China
  • Postdoctoral Training, Ophthalmology, University of California, San Francisco, California
  • Postdoctoral Training, Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
  • MS, Pharmacology, University of Sherbrooke, Sherbrooke, Canada
  • MPH, MS, Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Research Summary

Basic science research on animals is the first step before any pharmaceutical drugs can be used to treat human diseases. We used the light damage model of retinal degeneration to test the efficacy and toxicity of neuroprotective drugs in providing protection of retinal photoreceptor cells from cell death. Our studies also provide the information of susceptibility to light in SD, SDCD, Wistar, and Long-Evans rats, which is necessary for drugs studies on prevention and protection of retinal degeneration.

Recent Publications

Click here for a list of this investigator's publications.